Free Trial

FiscalNote (NOTE) Competitors

FiscalNote logo
$0.53 -0.02 (-3.21%)
Closing price 08/14/2025 03:58 PM Eastern
Extended Trading
$0.54 +0.01 (+1.52%)
As of 08/14/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NOTE vs. NRC, LTBR, PAYS, TRAK, OOMA, OPRX, SHAP, AHG, TRVG, and OABI

Should you be buying FiscalNote stock or one of its competitors? The main competitors of FiscalNote include National Research (NRC), Lightbridge (LTBR), Paysign (PAYS), ReposiTrak (TRAK), Ooma (OOMA), OptimizeRx (OPRX), Spree Acquisition Corp. 1 (SHAP), Akso Health Group (AHG), Trivago N.V. ADS (TRVG), and OmniAb (OABI). These companies are all part of the "business services" industry.

FiscalNote vs. Its Competitors

FiscalNote (NYSE:NOTE) and National Research (NASDAQ:NRC) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

National Research has a net margin of 12.78% compared to FiscalNote's net margin of -41.79%. National Research's return on equity of 83.52% beat FiscalNote's return on equity.

Company Net Margins Return on Equity Return on Assets
FiscalNote-41.79% -60.80% -18.61%
National Research 12.78%83.52%18.05%

54.3% of FiscalNote shares are owned by institutional investors. Comparatively, 47.3% of National Research shares are owned by institutional investors. 40.2% of FiscalNote shares are owned by insiders. Comparatively, 8.1% of National Research shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

National Research has higher revenue and earnings than FiscalNote. FiscalNote is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FiscalNote$120.27M0.69$9.52M-$0.32-1.65
National Research$143.06M2.39$24.78M$0.7619.74

FiscalNote has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, National Research has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.

In the previous week, FiscalNote had 11 more articles in the media than National Research. MarketBeat recorded 15 mentions for FiscalNote and 4 mentions for National Research. National Research's average media sentiment score of 0.73 beat FiscalNote's score of 0.26 indicating that National Research is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FiscalNote
2 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
National Research
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

FiscalNote currently has a consensus target price of $2.44, indicating a potential upside of 362.52%. Given FiscalNote's stronger consensus rating and higher possible upside, analysts plainly believe FiscalNote is more favorable than National Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FiscalNote
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
National Research
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

National Research beats FiscalNote on 9 of the 17 factors compared between the two stocks.

Get FiscalNote News Delivered to You Automatically

Sign up to receive the latest news and ratings for NOTE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NOTE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NOTE vs. The Competition

MetricFiscalNoteTechnology Services IndustryBusiness SectorNYSE Exchange
Market Cap$86.15M$2.66B$22.29B$21.04B
Dividend YieldN/A1.53%2.80%3.56%
P/E Ratio-1.6522.8527.7628.01
Price / Sales0.6936.8541.8257.05
Price / CashN/A46.0127.3723.95
Price / Book0.816.305.685.26
Net Income$9.52M$33.51M$198.41M$994.11M
7 Day Performance-7.58%1.13%1.21%2.09%
1 Month Performance-15.54%-2.31%-0.64%2.35%
1 Year Performance-56.45%33.77%28.10%13.36%

FiscalNote Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOTE
FiscalNote
3.6728 of 5 stars
$0.53
-3.2%
$2.44
+362.5%
-57.5%$86.15M$120.27M-1.65790Earnings Report
Analyst Forecast
NRC
National Research
2.9752 of 5 stars
$15.09
-0.1%
N/A-29.1%$343.75M$143.06M19.86490
LTBR
Lightbridge
0.3536 of 5 stars
$13.50
-2.0%
N/A+549.4%$310.23MN/A-16.076News Coverage
Earnings Report
PAYS
Paysign
4.0331 of 5 stars
$5.61
flat
$8.56
+52.6%
+18.0%$305.46M$58.38M46.7580
TRAK
ReposiTrak
0.5438 of 5 stars
$16.57
-0.6%
N/AN/A$302.90M$20.45M48.7470
OOMA
Ooma
2.3214 of 5 stars
$10.97
-0.9%
$17.63
+60.7%
+40.9%$302.63M$259.38M-57.711,186
OPRX
OptimizeRx
1.224 of 5 stars
$16.18
-6.5%
$11.81
-27.0%
+110.4%$299.33M$92.13M-29.96100High Trading Volume
SHAP
Spree Acquisition Corp. 1
N/A$10.91
flat
N/AN/A$283.07MN/A0.00N/A
AHG
Akso Health Group
0.579 of 5 stars
$1.73
+1.2%
N/A+73.8%$252.10M$8.45M0.0040
TRVG
Trivago N.V. ADS
2.3318 of 5 stars
$3.45
-3.4%
$4.35
+26.1%
+67.0%$242.57M$498.74M-345.00710Short Interest ↓
OABI
OmniAb
2.9528 of 5 stars
$1.96
-0.5%
$6.67
+240.1%
-51.3%$239.39M$23.03M-3.277

Related Companies and Tools


This page (NYSE:NOTE) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners